Related references
Note: Only part of the references are listed.A fully coupled computational fluid dynamics - agent-based model of atherosclerotic plaque development: Multiscale modeling framework and parameter sensitivity analysis
Anna Corti et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone
Eleonora Dondossola et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Size Matters: Metastatic Cluster Size and Stromal Recruitment in the Establishment of Successful Prostate Cancer to Bone Metastases
Arturo Araujo et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2018)
Current perspectives on bone metastases in castrate-resistant prostate cancer
Christopher Logothetis et al.
CANCER AND METASTASIS REVIEWS (2018)
A twofold usage of an agent-based model of vascular adaptation to design clinical experiments
Stefano Casarin et al.
JOURNAL OF COMPUTATIONAL SCIENCE (2018)
Vascular Adaptation: Pattern Formation and Cross Validation between an Agent Based Model and a Dynamical System
Marc Garbey et al.
JOURNAL OF THEORETICAL BIOLOGY (2017)
Radium 223 dichloride for prostate cancer treatment
Emmanuel Deshayes et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
C. Brooke Steele et al.
CANCER (2017)
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
Mari I. Suominen et al.
CLINICAL CANCER RESEARCH (2017)
Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
Leah M. Cook et al.
SCIENTIFIC REPORTS (2016)
Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer
Yu-Chen Lee et al.
CANCER RESEARCH (2015)
Mechanisms of osteolytic and osteoblastic skeletal lesions
G. David Roodman et al.
BONEKEY REPORTS (2015)
Bone-targeting agents in prostate cancer
Daniel L. Suzman et al.
CANCER AND METASTASIS REVIEWS (2014)
An Integrated Computational Model of the Bone Microenvironment in Bone-Metastatic Prostate Cancer
Arturo Araujo et al.
CANCER RESEARCH (2014)
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Oliver Sartor et al.
LANCET ONCOLOGY (2014)
Distribution of Metastatic Sites in Patients With Prostate Cancer: A Population-Based Analysis
Giorgio Gandaglia et al.
PROSTATE (2014)
Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
Mari I. Suominen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Computational Medicine: Translating Models to Clinical Care
Raimond L. Winslow et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006
N. Sathiakumar et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
New molecular targets in bone metastases
D. Santini et al.
CANCER TREATMENT REVIEWS (2010)
High-linear energy transfer irradiation targeted to skeletal metastases by the α-emitter 223Ra:: Adjuvant or alternative to conventional modalities?
Oyvind S. Bruland et al.
CLINICAL CANCER RESEARCH (2006)